Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor class drugs

1 result
Theratechnologies Inc.
Usage: TROGARZO is indicated for treating HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1, specifically for those failing their current antiretroviral regimen when used in combination with other antiretroviral therapies.